We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
- Authors
Chappuis, François; Udayraj, Nitya; Stietenroth, Kai; Meussen, Ann; Bovier, Patrick A
- Abstract
Patients with second-stage human African trypanosomiasis treated with eflornithine (n = 251) in 2003 in Kiri, southern Sudan, had an adjusted relative risk of death of 0.2 and experienced significantly fewer cutaneous and neurological adverse effects than did patients who were treated with melarsoprol in 2001 and 2002 (n = 708).
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Vol 41, Issue 5, p748
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1086/432576